The mission of our Neurocritical Care Center is to provide patients with around-the-clock access to neurointensivists and other neurocritical care specialists who use evidence-based, patient-centered protocols to treat neurologic injuries.
The Advantage of Innovative Care
Our 16-bed, dedicated neuroscience ICU uses state-of-the-art technology such as intracranial pressure monitoring, brain oxygen monitoring and ultrasound imaging techniques to provide critically ill patients with specialty care services for conditions such as complicated stroke, ruptured brain aneurysm, intracerebral hemorrhage, traumatic brain injury and acute spinal cord injury.
Comprehensive treatment is provided through detailed, daily teaching rounds which include nurses, residents, fellows and a multidisciplinary team of physical and occupational therapists, respiratory therapists, nutritionists and social workers. Treatment includes multi-modality monitoring, depending on the severity of the neurologic injury as well as a portable CAT scan, which is housed in the neuroscience ICU for emergent imaging.
Team-Based Model Ensures Continuity and Quality
A team-based model of care ensures that, upon admission, patients are followed by the same neurointensivists, critical care nurses, social workers and other health providers throughout their length of stay. This continuity ensures coordinated, seamless care, and excellent communication between the medical team and patients and their families. Overall, this approach increases quality of care and patient satisfaction. In addition, we regularly evaluate patient length of stay and readmission rates.
Communication with the patient's family is imperative. Our social services team reaches out to family and caregivers on a daily basis to discuss and educate families about the patient's clinical status and pertinent illnesses. Our Neurocritical Care Center has incorporated a child life team to arrange visitation for even the youngest visitors.
Clinical Pathways, Research and Education
Our specialists are using their expertise to develop clinical pathways for treating brain hemorrhage and brain aneurysm, as well as guidelines for intravenous sedation and anticoagulant prophylaxis for deep vein thrombosis.
Our center is also actively involved in domestic and international research trials. We are currently part of a multicenter clinical trial, MISTIE (Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation) which uses a thrombolytic or CT-guided endoscope to treat intracerebral hemorrhage as quickly as possible. This approach may reduce mortality and improve neurologic functioning and quality of life in our patients.
Neurosciences Institute in the news See more
- After 'mini-stroke,' drug combo could help cut odds for major attack
- Alessandro Di Rocco, MD named director, Northwell Health's movement disorders program
- Di Rocco named director of movement disorders
- Movement disorders neurologist joins Northwell
- Lenox Hill successfully treats metastatic brain cancer